我国基本药物可及性评估指标体系实证研究

The validation of an indicator system of essential drug accessibility assessment in China

对我国基本药物可及性进行实证研究,分析影响基本药物可及性的各个方面的因素,探寻各利益相关方对这项工作的反馈意见。运用结构方程模型方法,建立一个与基本药物可及性多层次、多因素等特点相适合的量化模型。本文构建的各项指标均对基本药物可及性的评估具有显著意义,并符合研究假设,即各个指标对我国基本药物可及性有显著影响作用。政策和行政资源的投入、质量监管、生产供应作为基本药物制度建设的主要对象,成为基本药物可及性评估的最重要指标,而由于我国目前的药品管理结构对基本药物制度建设的影响不大,组织结构成为影响力最小的指标。

To validate an indicator system of essential drug accessibility in China. The factors that affect the accessibility of essential drugs were studied and the reactions of interest-related main bodies upon this study were seeked. The structural equation model was applied to build a quantitative model adapted to the multilevel,multi-factor and other properties of essential drug accessibility. The indicators included in the constructed indicator system were all significantly applicable in the assessment of essential drug accessibility and conformed to the assumption that every indicator had significant influence on the essential drug accessibility. The investment of political and administrative resources,quality supervision and production supply should be the focuses of the development of essential drug system and the major indicators in the essential drug assessment. The organization structure is the least influential factor,because the structure of pharmaceutical regulation system of our country has minor influence on the construction of essential drug system.